Tuflex

SOMATEX launches new breast localization system on US market

Tuflex can stay in place overnight and uncouples the marking from the excision procedure. Tuflex can help in avoiding scheduling conflicts, particularly with early morning surgeries.

Our news

14.1.2021

Tumark® Vision: Highest detection rate in SenTa-Study

News

5.1.2021

SOMATEX® is now part of Hologic!

News

15.12.2020

Product Manager (m/w/d)

Job ad


03.12.2020

New: SurgLite with 4 hours runtime!

News

17.11.2020

Long awaited results of SenTa trial published!

News

16.10.2020

Technical product manager medical devices (m/w/d)

Job ad

Our products in clinical use

Short video clips show everyday clinical practice in the breast center of the Evang. Kliniken Essen-Mitte in Essen, Germany. In action: our Tumark Vision, Duo System, Somacore Verify and Core Biopsy Needle. Watch these videos about wire marking, breast biopsy and marking of breast lesions here.

At SOMATEX, we develop products that exceed the standard. To do this, we are closely collaborating with doctors and specialists in the medical fields in order to transfer their requirements into innovative product solutions. As a medtech company we have become experts for breast tumor localization, worldwide.

Nils Drewes, General Sales Director

Tumark® Vision Atlas
Case studies

The Tumark Vision Atlas contains case studies of the Tumark Vision biopsy site marker and provides clinical information. The long-term visibility of a biopsy site marker is particularly important in neoadjuvant chemotherapy. Some of the following case studies report this application scenario.

Contact us.

Consent

6 + 1 =